Author: Cipla USA Inc.

Posted Date:

April 23, 2026

Cipla Receives U.S. FDA Approval for First AB-Rated Generic of Ventolin® HFA

Cipla USA Inc.

April 23, 2026
Cipla Expands U.S. Respiratory Portfolio with Approval of Nintedanib Capsules (100mg & 150mg) for Idiopathic Pulmonary Fibrosis

Cipla USA Inc.

April 2, 2026
Cipla strengthens US portfolio with the launch of generic Saxenda® (Liraglutide Injection) for weight management therapy

Cipla USA Inc.

February 27, 2026